ClinicalTrials.gg
CompletedNCT07643207AxiSens-01Updated Oct 13, 2026

Wearable Spine Assessment in Adults With and Without Low Back or Neck Pain

An observational study in Low Back Pain and Neck Pain, sponsored by Ashkan Vaziri. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Ashkan Vaziri · Observational

How we know

Updated Oct 13, 2026Now CompletedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
5
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Enrollment
78th of 85
5 · median 90
Started
2026
with 32 others
Observational
87 of 712
19 open now
Registered
698th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 78th largest by enrollment of the 85 observational ones that give a count, is one of 33 that started in 2026, is one of 87 observational ones, and was the 698th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

95 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

This is a single-site, prospective, observational, single-visit feasibility and validity study. Adult participants with and without low back or neck pain will be screened, consented, and enrolled to undergo a structured wearable-sensor-based spine assessment in a single on-site visit.

Approximately 20 participants will be enrolled at a single site:

  • Approximately 10 adults with self-reported chronic or subacute low back or neck pain (LBP/Neck Pain group)
  • Approximately 10 adults without current back or neck pain (Control group)

The AxiSens battery includes the Fingertip-to-Floor (FTF) test for lumbar flexion, the Chin-to-Chest (CTC) test for cervical flexion, a seated Trunk Stability Test on an unstable surface, the Cervical Flexor Endurance Test, the five-times sit-to-stand F5xSTS) test, and a brief functional task module covering overhead and forward reach.

To support intra-rater repeatability characterization, the AxiSens wearable assessment is performed twice within the same visit by a single trained operator, with sensor doffing and re-donning between the two assessments. A short rest interval is provided between the two assessments.

Following the on-site assessment, participants complete a brief end-of-session usability and tolerability questionnaire and the Technology Acceptance Model (TAM) questionnaire.

Read the detailed description

Low back and neck pain are among the most common, costly, and disabling musculoskeletal conditions in the United States and worldwide. Low back pain is the leading cause of years lived with disability globally, and neck pain is consistently within the top ten. Both are leading drivers of healthcare expenditure, exceeding spending on diabetes, heart disease, and cancer in some recent analyses. Despite this magnitude, the clinical assessment of spine function remains heavily reliant on subjective self-report and clinician examination, with limited use of objective, quantitative, point-of-care measurement tools.

Wearable sensors, particularly inertial measurement units (IMUs), have matured into a credible technology base for objective musculoskeletal assessment. Multiple research groups have published validation studies establishing the accuracy of IMU-based segmental kinematics against optical motion capture, and feasibility studies demonstrating the utility of wearable kinematics in occupational and clinical settings. Most published wearable-spine assessment work to date has focused on lumbar kinematics in isolation, with cervical kinematic assessment less well-developed and integrated full-spine kinematic assessment relatively rare.

Recent peer-reviewed work demonstrated the feasibility of using wearable IMU technology to objectively assess cervical and upper-back posture in high-risk professional populations during prolonged work tasks. This work established that IMU-based monitoring of upper-body kinematics is feasible in real-world settings and that the methodology generates objective, reproducible data suitable for biofeedback and longitudinal monitoring. The current study extends this established methodology to a broader spine assessment configuration covering cervical, thoracic, lumbar, and pelvic segments, and integrated with validated patient-reported outcome instruments to enable a holistic biopsychosocial assessment of spine function.

The objective of this study is to evaluate the ability of a wearable, multi-modal spine assessment system - AxiSens - to discriminate between adults with low back or neck pain and healthy controls, and to characterize its intra-rater repeatability and workflow feasibility. There is no investigational therapeutic intervention. All participants undergo the same wearable-sensor-based spine assessment procedures in a single on-site visit. Approximately 20 participants will be enrolled, comprising approximately 10 participants in the LBP/Neck Pain group and approximately 10 participants in the Control group.

To support intra-rater repeatability characterization within this single-visit design, the AxiSens wearable assessment is performed twice within the visit by a single trained operator, with sensor doffing and re-donning between the two assessments and a short rest interval. The two within-visit assessments support estimation of the intra-rater repeatability of AxiSens-derived kinematic and composite outcomes.

03

Conditions studied

  • Low Back Pain
  • Neck Pain

Keywords

  • wearables
  • low back pain
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy controls, individuals with neck pain, and individuals with low back pain.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female, aged 18-65 years
  • Fluent in English (able to speak and read)
  • Ambulatory without the need for a walking aid
  • Able to independently perform all study activities safely, as determined by the investigator
  • Willing and able to provide and comply with all study procedures

For LBP/Neck Pain participants:

  • Self-reported low back or neck pain present for at least 4 weeks (subacute or chronic), with current Numeric Pain Rating Scale (NPRS) score of 3 or higher in the past 7 days
  • No history of spine surgery within the past 12 months

For Control participants:

  • No current low back or neck pain (NPRS \< 2 in the past 30 days) and no history of spine condition or spine surgery

Exclusion criteria

Exclusion Criteria:

Participants meeting any of the following criteria will be excluded from the study:

  • History of spine fracture, spinal deformity (e.g., scoliosis with Cobb angle > 25°), or spinal cord injury
  • Active radicular signs requiring imaging or specialist referral, as determined by the investigator
  • Neurological, vestibular, or musculoskeletal condition that would interfere with safe performance of the study tasks
  • Pregnant individuals
  • Skin condition or adhesive sensitivity precluding sensor application
  • (BMI) \< 18 kg/m² or > 40 kg/m²
  • Inability to provide or comply with study procedures
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
5 participants (actual)
Patient registry
No

Groups and cohorts

  • Control

    Adults without low back or neck pain

  • Low back pain group

    Adults with low back pain

  • Neck Pain

    Adults with neck pain

06

What researchers measure

Primary outcomes

  1. Group discrimination between control/low back pain/neck pain - Peak lumbar flexion range of motion

    AxiSens system shall discriminate between groups based on peak lumbar flexion range of motion and lumbopelvic coordination ration during the Fingertip to Floor test.

    Time frame: Baseline Visit

  2. Group discrimination between control/low back pain/neck pain - Peak cervical flexion range of motion

    AxiSens system shall discriminate between groups based on peak cervical flexion range of motion and cervicothoracic coordination ration during the Chin to Chest test.

    Time frame: Baseline Visit

  3. Group discrimination between control/low back pain/neck pain - Angular variability

    AxiSens system shall discriminate between groups based on angular variability of the sagittal and frontal planes during the Trunk Stability test in eyes open and eyes closed conditions.

    Time frame: Baseline Visit

  4. Group discrimination between control/low back pain/neck pain - Cervical flexor endurance time

    AxiSens system shall discriminate between groups based on endurance time during the Cervical Flexor Endurance test.

    Time frame: Baseline Visit

  5. Group discrimination between control/low back pain/neck pain - Five times sit-to-stand completion time

    AxiSens system shall discriminate between groups based on completion time during the five times sit-to-stand test.

    Time frame: Baseline Visit

Secondary outcomes

  1. Numeric Pain Rating Scale

    The Numeric Pain Rating Scale (NPRS) is an 11-point, self-reported assessment tool where 0 means "no pain" and 10 represents the "worst pain imaginable." It is scored simply by recording the whole number indicated by the patient, usually evaluated for current, average, or worst pain levels.

    Time frame: Baseline Visit

  2. Neck Disability Index

    The Neck Disability Index (NDI) is a 10-question survey that measures how neck pain affects activities of daily life. Each section is scored from 0 to 5, where 5 is a worst outcome. The total is calculated as a percentage to determine the level of functional disability.

    Time frame: Baseline Visit

  3. Oswestry Disability Index

    The Oswestry Disability Index (ODI) is the gold standard patient-reported questionnaire used to quantify functional disability in individuals with low back pain. It evaluates 10 everyday activities, such as personal care, lifting, walking, and sleeping. Each of the 10 sections is rated on a 6-point scale from 0 to 5, where 0 indicates no disability and 5 represents the most severe disability.

    Time frame: Baseline Visit

  4. Pain, Enjoyment, General Activity (PEG-3)

    The PEG-3 is used to assess chronic pain. Patients rate their pain, enjoyment of life, and general activity on a scale of 0 to 10 based on the past week. A higher score indicates a worst outcome.

    Time frame: Baseline Visit

07

Study locations

1 site
  • BioSensics LLC
    Newton, Massachusetts 02458, United States
08

References and documents

Publications

  • Zulbaran-Rojas A, Rouzi MD, Zahiri M, Ouattas A, Walter CM, Nguyen H, Bidadi S, Najafi B, Lemole GM. Objective assessment of postural ergonomics in neurosurgery: integrating wearable technology in the operating room. J Neurosurg Spine. 2024 Apr 19;41(1):135-145. doi: 10.3171/2024.1.SPINE231001. Print 2024 Jul 1. PubMed 38626470 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2026 to primary completion in Jul 2026, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2026
First posted
Jun 11, 2026
StartActual
Jun 12, 2026
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 30, 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 13, 2026
Primary completion
Jul 15, 2026→Jul 1, 2026 (actual)
Oct 13, 2026
Enrollment
20 (estimated)→5 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Active, not recruiting→Completed
    Primary completion Jul 15, 2026→Jul 1, 2026 (now actual)
    Enrollment 20 (estimated)→5 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07643207
Lead sponsor
Ashkan Vaziri
Responsible party
Ashkan Vaziri (CEO and Founder, BioSensics) — Sponsor-investigator
First posted
Jun 11, 2026
Start date
Jun 12, 2026
Primary completion
Jul 1, 2026
Completion
Jul 30, 2026
Last update
Oct 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion